⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for bi 811283 (d1)

Every month we try and update this database with for bi 811283 (d1) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive TreatmentNCT00632749
Leukemia, Myelo...
BI 811283 (d 1 ...
Cytarabine
BI 811283 (d1)
Cytarabine
18 Years - Boehringer Ingelheim
BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive TreatmentNCT00632749
Leukemia, Myelo...
BI 811283 (d 1 ...
Cytarabine
BI 811283 (d1)
Cytarabine
18 Years - Boehringer Ingelheim
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: